Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference40 articles.
1. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialog Clin Neurosci. 2009;11:111–28.
2. Zhang X-X, Tian Y, Wang Z-T, Ma Y-H, Tan L, Yu J-T. The epidemiology of Alzheimer’s disease modifiable risk factors and prevention. J Prev Alzheimers Dis. 2021;8:1–9.
3. Lee J, Meijer E, Langa KM, Ganguli M, Varghese M, Banerjee J, et al. Prevalence of dementia in India: national and state estimates from a nationwide study. Alzheimers Dement. 2023;19:2898–912.
4. Chakrabarti SS, Bir A, Poddar J, Sinha M, Ganguly A, Chakrabarti S. Ceramide and sphingosine-1-phosphate in cell death pathways: relevance to the pathogenesis of Alzheimer’s disease. Curr Alzheimer Res. 2016;13:1232–48.
5. US Food and Drug Administration. Leqembi™ (lecanemab-irmb) injection, for intravenous use full prescribing information. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269s000lbl.pdf. Accessed 18 Apr 2023.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献